Downloads
Abstract
Background: Kidney transplantation in chronic renal failure patients with high anti-HLA antibodies is very difficult, very likely to occur acute rejection, Thus, it requires to have strong immunosuppressive regimens for pre-transplantation and post-transplantation.
Objectives:
1. Evaluate the results of kidney transplant in patients with high level of anti HLA antibodies.
2. Evaluate the effectiveness of the introduction therapy.
Patients and methods: There were 3 patients with high anti-HLA antibodies: 62%, 89% and 97%, HLA matching 2/6, 3/6 and 3/6, respectively, in the same blood group. A patient had a first kidney transplant (chronic rejection), 2 patients had a history of transfusion. All of them have had kidney transplantation at Hue Central Hospital from 2015 to 2017.
Results: All three patients received a successful kidney transplantation. There was one post-transplant acute rejection patient must be treated by acute rejection therapy and dialysis in 12 times; an anemic patient must be treated by EPO. All three patients discharge from hospital with normal renal function, clinical stability.
Conclusion: With high positive Anti HLA antibodies, kidney transplantation with can by tanssplanted with certain success rate. However, it is necessary to have strong immunosuppressive regimens, especially using induction therapy of ATG
References
Glotz D., Antoine C., Haymann J., Julia P., Duboust A. Bariety J. (2000), “Transplantation rénale de patients immunisés dans le système HLA
et immunoglobulines intraveineuses”, Transplantation rénale de patients immunisés, pp125- 135.
Pérez-Flores I., Skhángago J.L., Calvo-Romero N., Barrientos-Guzmán A., Sánchez-Fructuoso A.I. (2013), “Different Impact of Pretransplant
Kháng-HLA Khángbodies Detected by Luminex in Highly Sensitized Renal Transplanted Patients”, BioMed Research International, Volume
, Article ID 738404, pp.1-5. http://dx.doi. org/10.1155/2013/738404
Campos É.F., Tedesco-Silva H., Machado P.G., Franco M., Medina-Pestana, Gerbase-DeLima M. (2006), “Post-Transplant Anti-HLA Class II
Antibodies as Risk Factor for Late Kidney Allograft Failure”, American Journal of Transplantation; (6), pp.2316–2320.
Dau P.C. (1995), “Increased antibody production in peripheral blood mononuclear cells after plasma exchange therapy in multiple sclerosis”, J Neuoimmunol, (62), pp.197-200.
Glotz D., Antoine C., Julia P. (2002), “Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins
(IVIg).”, Am J Transplant, pp.758-760.
Jordan S.C., Vo A., Bunnapradist S. et al (2003), “Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in livingdonor and cadaver recipients”, Transplantation, (76), pp.631-636.
Slatinska J., Honsova E., Burgelova M et al (2009), “Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: a single-center experience”, Therapeutic Apheresis Dialysis, (13), pp.108–112.
Stegall M.D., Gloor J., Winters J.L. et al (2006), “A Comparison of Plasmapheresis Versus High‐Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody”, Am J Transplant, (6), pp. 346-351. https://doi.org/10.1111/j.1600- 6143.2005.01178.x.
Viera C.A., Agarwal A., Book B.K. et al (2004), “Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1.
Safety, pharmacodynamics, and pharmacokinetics”, Transplantation,.Feb 27;77(4), pp.542-8.
| Published | 13-01-2025 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 57 (2019) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.2019.57.14 | |
| Keywords | Từ khóa: ghép thận, kháng thể kháng HLA, thuốc ức chế miễn dịch Keyword: renal transplantation, anti HLA antibodies, immunosuppressive regimens |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2019 Journal of Clinical Medicine Hue Central Hospital